Projects and Programmes
Projects and Programmes
![](https://ilds.contentfiles.net/media/images/Grand_Challenges_thumbnail.2e16d0ba.fill-400x400-c100.png)
The Grand Challenges in Global Skin Health initiative was put forth in 2015 to address the significant burden of skin diseases worldwide.
![](https://ilds.contentfiles.net/media/images/Chronic_Prurigo_square.2e16d0ba.fill-400x400-c100.png)
Established in 2023, this is a pioneering initiative aimed at standardizing definitions, terminology, and diagnostics for chronic prurigo diseases worldwide, including prurigo nodularis.
![](https://ilds.contentfiles.net/media/images/GLOVA_square.2e16d0ba.fill-400x400-c100.png)
Established in 2022, GLOVA is a comprehensive initiative dedicated to advancing our understanding of vitiligo and its societal impact.
![](https://ilds.contentfiles.net/media/images/GHiSA_square.2e16d0ba.fill-400x400-c100.png)
Launched in 2019 and collaborating with the ILDS since 2022, GHiSA aims to raise awareness and improve management of HS, a debilitating skin disease, through global collaboration and research. Led by Professor Gregor Jemec (Zealand University Hospital, Denmark), the GHiSA team has recently launched its first phase, publishing their inaugural global report in 2023.
![](https://ilds.contentfiles.net/media/images/GPA_square.2e16d0ba.fill-400x400-c100.png)
Established in 2017, GPA's mission is to provide a global benchmark on psoriasis burden, focusing on epidemiology, economic impact, comorbidities, and early diagnosis. Leveraging existing data and commissioning new studies, GPA aims to continuously enhance understanding and act as the premier global epidemiological resource on psoriasis.
![](https://ilds.contentfiles.net/media/images/GADA_square.2e16d0ba.fill-400x400-c100.png)
Established by the ILDS in 2022, GADA aims to compile comprehensive data on atopic dermatitis worldwide. By standardizing data collection and analysis, GADA seeks to provide vital insights for patients, caregivers, healthcare providers, and policymakers.
![](https://ilds.contentfiles.net/media/images/WCD_2019_Citation_Presentatio.2e16d0ba.fill-400x400-c100.jpg)
The ILDS, as part of its work in global dermatology, aims to recognise dermatologists and others in the field of dermatological care who have made an outstanding contribution to improving the experience for people with skin diseases.
![](https://ilds.contentfiles.net/media/images/General_GPEC_Image_20.2e16d0ba.fill-400x400-c100.png)
The aim of the GPEC programme is to improve the standard of dermatological education and care worldwide, through facilitating mutual learning partnerships between organisations. We seek to pair up dermatology departments to establish bi-directional knowledge exchange, furthering ILDS’ vision to attain the best possible skin health for all people around the world.
![](https://ilds.contentfiles.net/media/images/News_-_thumbnail_jnje0t2.2e16d0ba.fill-400x400-c100.jpg)
Our focus has been on psoriasis and as part of the WHO Global Coordination Mechanism
![](https://ilds.contentfiles.net/media/images/NNN.2e16d0ba.fill-400x400-c100.jpg)
Our focus has been on scabies and working with the WHO on the Integrated Management of NTDs
![](https://ilds.contentfiles.net/media/images/News_-_thumbnail.2e16d0ba.fill-400x400-c100.png)
The ILDS leads the Dermatology Topic Advisory Group (TAG) for the 11th revision of the ICD
![](https://ilds.contentfiles.net/media/images/TZ_dermlink_1.2e16d0ba.fill-400x400-c100.jpg)
DermLink is an annual grants programme that provides support for ILDS Member organisations to undertake one-off projects and initiatives to improve the treatment of patients with skin disease in under-served parts of the world.